ARTICLE | Company News
Antigen Express Inc. other research news
April 9, 2001 7:00 AM UTC
Antigen received a $192,000 Phase I SBIR grant from the National Cancer Institute to develop a prostate cancer vaccine based on the induction of MHC class II and suppression of Ii protein expression i...